Liju Zong
- Obstetrics and Gynecology top 5%
- Endometrial and Cervical Cancer Treatments 8
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers 13
- Immunology top 10%
- Immunotherapy and Immune Responses 6
- Reproductive Medicine top 10%
-
- Gestational Trophoblastic Disease Studies 10
-
- Prenatal Screening and Diagnostics 6
-
- Colorectal and Anal Carcinomas 6
-
- Neuroendocrine Tumor Research Advances 4
- Cervical Cancer and HPV Research 4
- Journals
- The Lancet Oncology (1 paper)Experimental Cell Research (1 paper)BioMed Research International (1 paper)
- Partner nations
- China
In The Last Decade
Liju Zong
37 papers receiving 723 citations
Peers
Comparison fields: 5 of 53
- Obstetrics and Gynecology 130
- Oncology 410
- Immunology 237
- Reproductive Medicine 56
- Cancer Research 73
Countries citing papers authored by Liju Zong
This map shows the geographic impact of Liju Zong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liju Zong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liju Zong more than expected).
Fields of papers citing papers by Liju Zong
This network shows the impact of papers produced by Liju Zong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liju Zong. The network helps show where Liju Zong may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Liju Zong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2023 | 15 | |
| 3 | 2023 | 9 | |
| 4 | 2023 | 1 | |
| 5 | 2022 | 3 | |
| 6 | 2021 | 1 | |
| 7 | 2021 | 10 | |
| 8 | 2021 | 60 | |
| 9 | 2021 | 27 | |
| 10 | 2021 | 10 | |
| 11 | 2020 | 23 | |
| 12 | 2019 | 9 | |
| 13 | 2019 | 26 | |
| 14 | 2019 | 72 | |
| 15 | 2019 | 24 | |
| 16 | 2018 | 40 | |
| 17 | 2018 | 20 | |
| 18 | 2018 | 32 | |
| 19 | 2017 | 8 | |
| 20 | 2015 | 5 |
About Liju Zong
Liju Zong is a scholar working on Obstetrics and Gynecology, Oncology and Immunology, having authored 37 papers that have together received 725 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (13 papers), Gestational Trophoblastic Disease Studies (10 papers), Endometrial and Cervical Cancer Treatments (8 papers), Prenatal Screening and Diagnostics (6 papers), Immunotherapy and Immune Responses (6 papers), Colorectal and Anal Carcinomas (6 papers), Neuroendocrine Tumor Research Advances (4 papers) and Cervical Cancer and HPV Research (4 papers). The work is most often cited by research in Obstetrics and Gynecology (130 citations), Oncology (410 citations) and Immunology (237 citations). Liju Zong has collaborated with scholars based in China. Frequent co-authors include Yang Xiang, Jie Chen, Shuangni Yu, Junjun Yang, Shengwei Mo, Yujia Kong, Xirun Wan, Zhaohui Lu, Ming Zhang and Ming Zhang. Their work appears in journals such as The Lancet Oncology, Experimental Cell Research and BioMed Research International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.